Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go

Wilms‘ Tumor Gene 1 (WT1)–loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial

Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer

Myeloid-derived suppressor cells in glioma

Dendritic cell-based immunotherapy in ovarian cancer

Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma

[Immunotherapy and hyperthermia for the treatment of patients with advanced or recurrent colorectal cancer]

Dendritic cell vaccine for recurrent high-grade gliomas in pediatric and adult subjects: clinical trial protocol

[The effect of immunotherapy and hyperthermia on patients with advanced or recurrent breast cancer]

Dendritic cells, inflammation, and breast cancer